Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 323 results found. Search for [ new drug against coronavirus ]

Results 40 to 60 of 323
BusinessToday.In
January 27, 2021
The American biotech company said its two-antibody cocktail, REGEN-COV, caused a 100% reduction in symptomatic infection and roughly 50% lower overall rates of infection


BusinessToday.In
January 27, 2021
Coronvirus treatment: Plitidepsin, according to the researchers, should be considered for clinical trials based on its in vivo study results. Plitidepsin aka Aplidin is owned by Spanish pharmaceutical company Pharma Mar


PB Jayakumar
January 26, 2021
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months


PTI
January 24, 2021
The government has given a go-ahead to a local pharmaceutical company for the import and distribution of the Russia-developed Sputnik V, the Dawn newspaper quoted an official as saying


PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet


Rajeev Dubey | Vivek Punj
January 11, 2021
Full authorisation-better known as \"full pre-qualification\"-is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers


BusinessToday.In
January 8, 2021
Bharat Biotech chairman Krishna Ella says this nasal vaccine will revolutionise Indian vaccine making capabilities and help it leapfrog along with Europe, the US and China


Yasmin Ahmed
New Delhi, January 7, 2021
The government's CoWIN app is still under development or the pre-production stage and will soon be available to Android and iOS users to download for free and will be \"adequately publicised\" on launch, noted the Ministry of Health.


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


Associated Press
January 4, 2021
Experts believe that the real numbers of US deaths and infections are much higher and that many cases were overlooked, in part because of insufficient testing


BusinessToday.In
January 3, 2021
The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come


BusinessToday.In
January 3, 2021
Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people


PTI
January 3, 2021
A study suggests that chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19


BusinessToday.In
January 3, 2021
COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi


BusinessToday.In
January 2, 2021
The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter


Manoj Sharma
December 31, 2020
Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves


PTI
December 30, 2020
As per the report, Matthew's condition has improved since his symptoms peaked on Christmas Day but still feels fatigued


BusinessToday.In
December 29, 2020
It is important from the scientific community perspective that we do not put too much immune pressure on the virus, said Bhargava


BusinessToday.In
December 27, 2020
Soriot said, \"We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else\"


PTI
December 27, 2020
The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups


PAGES 3 OF 17  12345